Skip to content

Ovid Therapeutics Inc.

OVID · XNAS

CIK 1636651fmd_098YX8WY9Z5HMF20K884W8BBCNManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2015 to Sep 30, 2026, 44 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading